Abstract
A 61-year-old woman, with a 25-year history of maintenance hemodialysis due to end-stage renal disease of unknown causes, was admitted because of systemic joint pain and inflammatory response of unknown etiology that persisted for 1 month. Laboratory data on admission revealed leukocytopenia, lymphocytopenia, high serum C-reactive protein, and positivity for antinuclear antibody (ANA) and anti-double strand DNA. After admission, she progressively developed cough and dyspnea. A chest radiograph revealed bilateral ground glass opacity and pleural effusion. A thoracentesis revealed lupus erythematosus cells, suggesting lupus pleuritis. A chest computed tomography showed a pattern of diffuse alveolar damage compatible with acute lupus pneumonitis. She fulfilled the American Rheumatism Association diagnostic criteria for systemic lupus erythematosus (SLE). Methylprednisolone pulse therapy followed by oral prednisone treatment improved the clinical symptoms and laboratory abnormalities. ANA was negative 25 years earlier when she first started hemodialysis and she had neither clinical nor serological abnormalities related to SLE during the last 25 years. Further, she had neither received drugs that can cause drug-induced SLE, nor had a history of ultraviolet ray exposure, pregnancy, blood transfusion, trauma and smoking. This report suggests that new-onset SLE can develop in patients undergoing long-term dialysis. Hence, when we encounter dialysis patients with arthralgia and/or respiratory disorders, we should consider the possibility of new-onset SLE.
References
Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365:2110–21.
Cheigh JS, Kim H, Stenzel KH, Tapia L, Sullivan JF, Stubenbord W, Riggio RR, Rubin AL. Systemic lupus erythematosus in patients with end-stage renal disease: long-term follow-up on the prognosis of patients and the evolution of lupus activity. Am J Kidney Dis. 1990;16:189–95.
Coplon NS, Diskin CJ, Peteesen J, Swenson RS. The long-term clinical course of systemic lupus erythematosus in end-stage renal disease. N Engl J Med. 1983;308:186–90.
Ribeiro FM, Leite MA, Velarde GC, Fabris CL, Santos RC, Lugon JR. Activity of systemic lupus erythematosus in end-stage renal disease patients: study in a Brazilian cohort. Am J Nephrol. 2005;25:596–603.
Krane NK, Burjak K, Archie M, O’donovan R. Persistent lupus activity in end-stage renal disease. Am J Kidney Dis. 1999;33:872–9.
Hernandez-Jaras J, Bernis C, Paraiso V, Barril G, Alvarez V, Traver JA. Development of systemic lupus erythematosus in a patient on hemodialysis. Am J Nephrol. 1992;12:105–7.
Kasama RK, Shusterman NH, Rocco MV. The de novo diagnosis of systemic lupus erythematosus in a hemodialysis patient. J Clin Rheumatol. 1996;2:160–2.
Lee DH, Davis WE, Quinet RJ. New-onset systemic lupus erythematosus during chronic dialysis and after transplantation for idiopathic renal failure. J Clin Rheumatol. 1997;3:282–5.
Vaziri ND, Pahl MV, Crum A, Norris K. Effect of uremia on structure and function of immune system. J Ren Nutr. 2012;22:149–56.
Gagnon RF, Shuster J, Kaye M. Auto-immunity in patients with end-stage renal disease maintained on hemodialysis and continuous ambulatory peritoneal dialysis. J Clin Lab Immunol. 1983;11:155–8.
Pisetsky DS. Immune activation by bacterial DNA: a new genetic code. Immunity. 1996;5:303–10.
Maddison PJ. Systemic lupus erythematosus in the elderly. J Rheumatol Suppl. 1987;14:182–7.
Baker SB, Rovira JR, Campion EW, Mills JA. Late onset systemic lupus erythematosus. Am J Med. 1979;66:727–32.
Boddaert J, Huong DL, Amoura Z, Wechsler B, Godeau P, Piette JC. Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine (Baltimore). 2004;83:348–59.
Torre O, Harari S. Pleural and pulmonary involvement in systemic lupus erythematosus. Presse Med. 2011;40:e41–51.
Keane MP, Lynch JP 3rd. Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax. 2000;55:159–66.
ter Borg EJ, Horst G, Limburg PC, van Rijswijk MH, Kallenberg CG. C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study. J Rheumatol. 1990;17:1642–8.
Wiedemann HP, Matthay RA. Pulmonary manifestation of the collagen vascular disease. Clin Chest Med. 1989;10:677–722.
Sarkar S, Saha K. Bilateral acute lupus pneumonitis in a case of rhupus syndrome. Lung India. 2012;29:280–2.
Naylor B. Cytological aspects of pleural, peritoneal and pericardial fluids from patients with systemic lupus erythematosus. Cytopathology. 1992;3:1–8.
Park JY, Malik A, Dumoff KL, Gupta PK. Case report and review of lupus erythematosus cells in cytology fluids. Diagn Cytopathol. 2007;35:806–9.
Gulhane S, Gangane N. Detection of lupus erythematosus cells in pleural effusion: an unusual presentation of systemic lupus erythematosus. J Cytol. 2012;29:77–9.
Acknowledgments
We thank Edanz Editing (http://www.edanzediting.co.jp/) for carefully reading and preparing our manuscript.
Conflict of interest
Honoraria: Kazuhiko Tsuruya (Kyowa Hakko Kirin Co., Chugai Pharmaceutical Co.), Research funding: Kazuhiko Tsuruya (Kyowa Hakko Kirin Co., Chugai Pharmaceutical Co., Fuso Pharmaceutical Industries, MSD K.K., Takeda Pharmaceutical Co.), Endowed department: Kazuhiko Tsuruya (Baxter).
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Hiyamuta, H., Yamada, S., Yotsueda, R. et al. New-onset systemic lupus erythematosus in a long-term hemodialysis patient with acute pleuritis and pneumonitis. CEN Case Rep 4, 139–144 (2015). https://doi.org/10.1007/s13730-014-0155-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13730-014-0155-9